MODULATING INFLAMMATION ASSOCIATED WITH FOREIGN BODY RESPONSE
Number of patents in Portfolio can not be more than 2000
United States of America
Stats
-
N/A
Issued Date -
Mar 20, 2025
app pub date -
Sep 14, 2024
filing date -
Sep 14, 2024
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Disclosed herein include methods, compositions, and kits suitable for use in producing insulin in a mammalian subject. In some embodiments, the method comprises implanting a perforated cell delivery device comprising a genetically modified cell or population thereof into the subject. Also provided are combination products comprising the perforated cell delivery device comprising a genetically modified cell or population thereof.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully